Meet Our Featured Speakers

benefits

ADC Summit 2026 features leading market insights and industry experts discussing the latest advancements in ADC molecule development, safety strategies, scalable manufacturing, supply chain readiness, and regulatory expectations.

Benefits of attending include:

Two days of focused presentations where ADC teams share real program insights, key results, and practical experiences.
An exclusive networking opportunity to connect with professionals who share similar challenges and experiences across past and current ADC development programs.
Updates on recent regional ADC projects and R&D from leading biopharma professionals, highlighting key findings, common challenges to monitor, and ideas shaping next-stage development.
Technical presentations from ADC technology and CDMO partners on conjugation platforms, linker and payload selection, analytics, and scalable manufacturing, enabling attendees to benchmark approaches and avoid scale-up challenges.
New case studies spanning discovery to clinical stages, demonstrating how teams predict and mitigate toxicity, manage heterogeneous tumors, and address resistance through payload strategy, sequencing, and combination approaches.
Actionable clinical and regulatory insights for ADC readiness, covering trial design, dosing strategies, bioanalysis, CMC alignment, and risk management to strengthen submissions and approval pathways.

key takeaways

Gain an understanding of the latest ADC landscape and its implications for your development strategy
Learn practical approaches to enhancing ADC performance and safety
Hear what’s next in ADC development, targets, and combination strategies
Discuss scalable manufacturing, analytics, and supply chain readiness for ADCs
Access broad perspectives from biopharma, CDMOs, and technology partners across regions

who should attend?

This event is intended for biopharma and biotech ADC developers, oncology drug teams, CDMOs and CROs, and enabling technology providers seeking to enhance ADC development, reduce toxicity, scale manufacturing, and strengthen clinical and regulatory readiness.

Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, and Managers involved in:

ADC Characterization Drug Formulation Regulatory Affairs ADC Discovery Chemistry Equipment Certification Research and Development ADC Manufacturing IP and Regulations Resistance Biology Antibody Engineering Linker Design & Strategy Sales and Marketing Bioconjugation Strategy Materials Sourcing and Advisory Supply Chain Management Bispecifics Development News Reporting and Journalism Target Biology Business Development Purchasing and Sourcing Translational Medicine CMC Strategy Quality Assurance Vendor Management

they've attended our events

Brett Hill

Arcturus Therapeutics

"The conference provides great exposure to industry leaders."

Xu Han

Orna Therapeutics

"Inspiring event covering a broad range of insightful and highly relevant topics."

Alice Spenlehauer

DNA Script

"The session was of excellent quality."

Daniel Dixon

TriLink BioTechnologies

"High-quality forum featuring excellent content."

Ramesh Dasari

Sanofi

"A great program with strong coverage of ionizable lipid design and bioanalytical methods."

Muriel Lemaitre

Hongene Biotech Corporation

"A standout experience offering insightful speakers and excellent networking potential."

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.